Clinical • Metastases
|
B2M (Beta-2-microglobulin) • HLA-DQB1 (Major Histocompatibility Complex, Class II, DQ Beta 1) • HLA-B (Major Histocompatibility Complex, Class I, B) • HLA-DPB1 (Major Histocompatibility Complex, Class II, DP Beta 1) • HLA-DQA1 (Major Histocompatibility Complex, Class II, DQ Alpha 1) • HLA-DRA (Major Histocompatibility Complex, Class II, DR Alpha) • HLA-E (Major Histocompatibility Complex, Class I, E) • HLA-DPA1 (Major Histocompatibility Complex, Class II, DP Alpha 1) • TAP1 (Transporter 1) • HLA-C (Major Histocompatibility Complex, Class I, C)
|
CIITA rs4774 • ERAP1 rs26653 • HLA-B rs2770 • HLA-DMB rs10751 • HLA-DOB rs11244 • HLA-DPB1 rs3097671 • HLA-DRA rs7192 • HLA-G rs1610696 • TAP1 rs1135216 • TAP2 rs1044043 • TAP2 rs1800454 • TAPBP rs3106191 • TAP2 rs241447
|
Avastin (bevacizumab) • Erbitux (cetuximab) • 5-fluorouracil • irinotecan • leucovorin calcium